Literature DB >> 15989909

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.

Stein Orn1, John G F Cleland, Matti Romo, John Kjekshus, Kenneth Dickstein.   

Abstract

PURPOSE: The development of left ventricular systolic dysfunction or heart failure following an acute myocardial infarction (MI) is a powerful marker of an adverse prognosis. Recurrent MI could be an important cause of death, either directly or by provoking arrhythmias.
METHODS: The OPTIMAAL trial randomized 5477 patients with heart failure or evidence of left ventricular dysfunction following acute MI to losartan or captopril. Over a follow-up of 2.7 years, there were 946 deaths. Of the 180 (19%) of these deaths for which autopsy reports were available, acute MI was found in 57% (102 of 180) of the autopsies. By comparison, an endpoints adjudication committee using clinical data attributed death to acute MI in only 29 cases. An acute MI was found at autopsy in 55% (37 of 67) of the deaths that had been classified as due to an arrhythmia and in 81% (21 of 26) of the deaths classified as due to progressive heart failure. Including autopsy diagnoses, the rate of acute MI in patients who died suddenly was independent of the time elapsed since the index MI, but in patients not classified as dying suddenly, there was a time-related decrease in recurrent MI from 78% in the first 30 days to 30% by the end of follow-up. However, only 19% of patients who died underwent autopsy, so recurrent MI may have been substantially more common and perhaps had a different relation to time since the index MI if more patients had undergone autopsy.
CONCLUSIONS: In patients with evidence of major cardiac dysfunction after MI, recurrent MI found at autopsy is common and has often not been clinically detected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989909     DOI: 10.1016/j.amjmed.2005.02.010

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Symptom clusters predict event-free survival in patients with heart failure.

Authors:  Eun Kyeung Song; Debra K Moser; Mary K Rayens; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2010 Jul-Aug       Impact factor: 2.083

2.  Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events.

Authors:  Isabel Coma-Canella; Jorge Palazuelos; Nieves Bravo; María José García Velloso
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

3.  Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

Authors:  Eun Kyeung Song; Debra K Moser; Susan K Frazier; Seongkum Heo; Misook L Chung; Terry A Lennie
Journal:  J Card Fail       Date:  2010-03-19       Impact factor: 5.712

4.  Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.

Authors:  Mihai Gheorghiade; James D Flaherty; Gregg C Fonarow; Ravi V Desai; Richard Lee; David McGiffin; Thomas E Love; Inmaculada Aban; Eric J Eichhorn; Robert O Bonow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2010-06-16       Impact factor: 4.164

5.  Clinical features of early recurrent myocardial infarction.

Authors:  Kenichi Sakakura; Norifumi Kubo; Junya Ako; Nahoko Ikeda; Hiroshi Funayama; Taishi Hirahara; Hiroshi Wada; Yoshitaka Sugawara; Takanori Yasu; Masanobu Kawakami; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

Review 6.  Role of antithrombotic agents in heart failure.

Authors:  John G F Cleland; Saqib Mumtaz; Luca Cecchini
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 7.  Antithrombotics in heart failure.

Authors:  Davor Miličić; Jure Samardžić; Mate Petričević
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

8.  Influence of case definition on incidence and outcome of acute coronary syndromes.

Authors:  Azam Torabi; John G F Cleland; Nasser Sherwi; Paul Atkin; Hossein Panahi; Eric Kilpatrick; Simon Thackray; Angela Hoye; Farqad Alamgir; Kevin Goode; Alan Rigby; Andrew L Clark
Journal:  Open Heart       Date:  2016-12-30

Review 9.  Anticoagulation in heart failure: current status and future direction.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Gregg C Fonarow; Stephen J Greene; Barry H Greenberg; Peter P Liu; Barry M Massie; Mandeep R Mehra; Marco Metra; Faiez Zannad; John G F Cleland; Dirk J van Veldhuisen; Ami N Shah; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 10.  Fighting against sudden death: a single or multidisciplinary approach.

Authors:  John G F Cleland; Periaswamy Velavan; Mansour Nasir
Journal:  J Interv Card Electrophysiol       Date:  2007-04-06       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.